Project Grant K08CA279913

Award Date 7/1/24
Completion Date 6/30/28
Dollars Obligated $287K
Federal Grant Program
93.398
Assistance Type
Project Grant
Place of Performance
Connecticut, USA
Similar Awards
This federal Project Grant award from the National Cancer Institute (CFDA 93.398 Cancer Research Manpower program) provides $192,780 to the University of Alabama at Birmingham to implement and optimize a bundled breast and cervical cancer screening program in a resource-limited setting in Cameroon, Sub-Saharan Africa. The goal is to enhance equitable global cancer control by improving the screening to diagnosis to treatment cascade and effectively disseminating the program. The research will...
This federal Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) provides $691,176 to Brigham & Women's Hospital Inc. to investigate implementation strategies for decentralizing diagnostic breast ultrasound services and improving timely breast cancer diagnoses in Rwanda. The project aims to compare the effectiveness of two supervision approaches - real-time teleultrasound and asynchronous virtual feedback - in facilitating high-quality,...
This Cooperative Agreement award from the National Cancer Institute (NCI), under the Cancer Cause and Prevention Research (CFDA 93.393) program, aims to develop and evaluate an evidence-based, behavioral cervical cancer screening intervention for women living with HIV in Ghana. The $511,959 award to Baylor University will fund a hybrid effectiveness-implementation trial to integrate and scale up a home-based HPV self-sampling and communication model intervention called HOPE. The project seeks to...
The National Cancer Institute (NCI) awarded a 5-year, $162,160 Project Grant (CFDA 93.398 - Cancer Research Manpower) to The Ohio State University to improve the assessment of patient-reported outcomes (PROs) among Black/African-American cancer patients. The research will involve qualitative interviews with Black cancer patients and their providers to understand barriers and facilitators to completing PROs and social determinants of health (SDH) measures. This knowledge will inform the...
This federal Project Grant award from the National Cancer Institute (CFDA 93.398 Cancer Research Manpower program) provides $197,640 to The General Hospital Corporation (doing business as Massachusetts General Hospital) to develop implementation strategies to initiate colorectal cancer (CRC) screening in previously unscreened individuals aged 45 to 54 at a predominantly Black community health center in Boston, Massachusetts. The key objectives are to: (1) identify system-level determinants of...
This $171,989 Project Grant awarded by the National Cancer Institute (CFDA 93.398 Cancer Research Manpower program) will support the University of Florida in adapting and evaluating the PINPOINT intervention to improve cervical cancer outcomes among women with chronic conditions and social vulnerability. The key products and services to be delivered under this five-year award include: 1) analyzing real-world health data to identify high-risk populations for cervical cancer, 2) using intervention...
This $251,519 Project Grant award from the National Cancer Institute's Cancer Research Manpower program (CFDA 93.398) will support the development, refinement, and pilot testing of a nurse-led coping and supportive care intervention called "TRANSITIONS" to address the psychosocial needs of patients with triple-negative breast cancer (TNBC) as they transition from curative therapy to surveillance. The Principal Investigator, Dr. Kathryn Post, will lead this 5-year project at...
This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $180,946 to develop and evaluate a stepped implementation approach for delivering problem-solving therapy to people living with HIV in South Africa. The key products and services to be delivered include: Determining stakeholder preferences for implementing problem-solving therapy through qualitative research with people living with HIV and HIV/mental...
The National Cancer Institute (NCI) awarded a $1,245,116 Cooperative Agreement under the Cancer Cause and Prevention Research (CFDA 93.393) program to Emory University to enhance cervical cancer screening and treatment for women living with HIV in Kenya. The project, titled "ENHANCING CERVICAL CANCER SCREENING AND TREATMENT IN WOMEN LIVING WITH HIV IN KENYA (ENHANCE LINKAGE)", will adapt and test evidence-based implementation strategies to overcome barriers to integrating cervical...
The federal Project Grant award R01CA299475, titled "DEVELOPMENT OF SYSTEMS AND EDUCATION FOR CERVICAL CANCER PREVENTION (DOSE-CC)", is funded by the National Cancer Institute (CFDA 93.393 Cancer Cause and Prevention Research program) for $753,446. The grant aims to adapt and test an intervention to improve cervical cancer screening and follow-up in three diverse, underserved populations: urban inner city Blacks/Haitians, Hispanic immigrants, and Hawaiian natives/Pacific Islanders. The...

DESIGNING IMPLEMENTATION STRATEGIES FOR INTRODUCING SCREENING CLINICAL BREAST EXAMINATION TO PRIMARY HEALTH CENTERS IN JOHANNESBURG, SOUTH AFRICA - PROJECT SUMMARY / ABSTRACT THE PRIMARY GOAL OF THIS RESEARCH PROPOSAL IS TO PROVIDE DR. O'NEIL WITH FOUR YEARS OF TRAINING AND RESEARCH EXPERIENCE IN IMPLEMENTATION SCIENCE AND MIXED-METHODS RESEARCH TECHNIQUES TO SUPPORT HIS TRANSITION TO BEING AN INDEPENDENT RESEARCHER FOCUSED ON IMPROVING THE EARLY DETECTION OF BREAST CANCER AND BREAST CANCER CARE MORE BROADLY IN LOW- AND MIDDLE-INCOME COUNTRIES (LMICS). BREAST CARE PATIENTS FROM LMICS FACE FAR HIGHER MORTALITY THAT PATIENTS FROM THE USA, IN PART BECAUSE A LACK OF SCREENING MAMMOGRAPHY RESULTS IN MORE THAN 50% BEING DIAGNOSED WITH STAGE III OR IV CANCER. BREAST CANCER SCREENING USING CLINICAL BREAST EXAM HAS BEEN SHOWN IT TO BE NEARLY AS EFFECTIVE AT DETECTING EARLY BC AS MAMMOGRAPHY AND CAPABLE OF DECREASING BC STAGE AT DIAGNOSIS AND MORTALITY. HOWEVER, SCREENING CBE (SCBE) HAS NOT BEEN WIDELY IMPLEMENTED IN LMICS, INCLUDING SOUTH AFRICA. DR. O'NEIL PROPOSES TO USE THE IMPLEMENTATION MAPPING PROCESS TO COLLABORATIVELY DESIGN AND PILOT A SET OF STRATEGIES FOR IMPLEMENTING SCBE IN THE PRIMARY HEALTH CENTERS (PHCS) OF SOWETO, SOUTH AFRICA. IN AIM 1, HE WILL ENGAGE WITH PROVIDER AND PATIENT STAKEHOLDERS AT FOUR PARTICIPATING PHCS TO CONDUCT A BASELINE NEEDS ASSESSMENT, IDENTIFY DETERMINANTS OF IMPLEMENTATION WITH CHANGE OBJECTIVES, SELECT APPLICABLE STRATEGIES, AND THEN PRODUCE IMPLEMENTATION MATERIALS. DETERMINANT AND STRATEGY SELECTION WILL BE ORGANIZED USING THE COM-B AND BEHAVIORAL WHEEL OF CHANGE FRAMEWORKS. IN AIM 2, DR. O'NEIL WILL CONDUCT A FEASIBILITY PILOT STUDY OF SCBE IMPLEMENTATION IN THE SAME FOUR PHCS, USING THE STRATEGIES DEVELOPED IN AIM 1. THIS STUDY WILL ALLOW FOR REFINEMENT OF THE STRATEGIES, AND THE PRIMARY OUTCOME WILL COMPARE RECEIPT OF SCBE AMONG ELIGIBLE WOMEN BEFORE AND AFTER IMPLEMENTATION. THESE RESULTS AND OTHER SECONDARY RESULTS FROM THE RE-AIM FRAMEWORK WILL PROVIDE PRELIMINARY DATA SUPPORTING AN R01 PROPOSAL FOR A LARGE-SCALE HYBRID TRIAL MEASURING THE EFFECTIVENESS AND IMPLEMENTATION SUCCESS OF THE SCBE IMPLEMENTATION PACKAGE DEVELOPED HERE. DR. O'NEIL HAS SUBSTANTIAL EXPERIENCE STUDYING BREAST CANCER CARE QUALITY AND BARRIERS TO CARE IN SUB-SAHARAN AFRICA. HIS TRAINING PLAN ADDS TO THAT FOUNDATION BY EMPHASIZING NEW SKILLS ESSENTIAL TO ACTUALLY IMPROVING CARE, WITH FORMAL INSTRUCTION IN THE THEORIES AND METHODS OF IMPLEMENTATION SCIENCE AND MIXED-METHODS RESEARCH. HIS MENTORING TEAM INCLUDES EXPERTS IN BREAST CANCER CLINICAL RESEARCH, IMPLEMENTATION SCIENCE, AND GLOBAL ONCOLOGY, WHO ARE UNIQUELY QUALIFIED TO SUPERVISE DR. O'NEIL'S RESEARCH PROGRAM AND TO HELP HIM EXPAND HIS ACADEMIC GLOBAL ONCOLOGY NETWORK. DR. O'NEIL WILL ALSO BE LEVERAGING HIS LONGSTANDING AND PRODUCTIVE PARTNERSHIP WITH BREAST CANCER RESEARCHERS AT THE UNIVERSITY OF WITWATERSRAND IN JOHANNESBURG, WHO WILL BE ENTHUSIASTIC COLLABORATORS IN THE PROPOSED WORK AND PROVIDE VITAL SUPPORT. THIS WORK WILL THE FIRST STEP TOWARDS SCALING-UP AND STUDYING BREAST CANCER SCREENING THROUGHOUT SOUTH AFRICA AND OTHER LMICS, A PUBLIC HEALTH GOAL WITH THE POTENTIAL TO DECREASE GLOBAL BREAST CANCER MORTALITY. IT WILL ALSO POSITION DR. O'NEIL FOR A SUCCESSFUL CAREER AS AN INDEPENDENT GLOBAL ONCOLOGY IMPLEMENTATION SCIENTIST.

Posted 6/10/24, 12:00 AM